Tower Research Capital LLC (TRC) - AERIE PHARMACEUTICALS INC ownership

AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 140 filers reported holding AERIE PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.82 and the average weighting 0.1%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of AERIE PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$66,000
+112.9%
4,342
+5.7%
0.00%0.0%
Q2 2022$31,000
+520.0%
4,109
+721.8%
0.00%
Q1 2022$5,000
-94.3%
500
-95.9%
0.00%
-100.0%
Q4 2021$87,000
+148.6%
12,330
+297.7%
0.00%
+100.0%
Q3 2021$35,000
-52.7%
3,100
-32.8%
0.00%
-50.0%
Q2 2021$74,000
-29.5%
4,615
-21.7%
0.00%0.0%
Q1 2021$105,000
+303.8%
5,895
+213.7%
0.00%
+100.0%
Q4 2020$26,000
-44.7%
1,879
-52.6%
0.00%0.0%
Q3 2020$47,000
-32.9%
3,968
-16.3%
0.00%
-66.7%
Q2 2020$70,000
+7.7%
4,742
+76.1%
0.00%
-40.0%
Q4 2019$65,000
+109.7%
2,693
+66.0%
0.01%
+150.0%
Q3 2019$31,000
-27.9%
1,622
+11.2%
0.00%
-33.3%
Q2 2019$43,000
+1333.3%
1,458
+2330.0%
0.00%
Q1 2019$3,000
-85.7%
60
-82.3%
0.00%
-100.0%
Q3 2018$21,000
-22.2%
339
-32.6%
0.00%0.0%
Q1 2018$27,000
+575.0%
503
+618.6%
0.00%
+100.0%
Q4 2017$4,000
-98.2%
70
-98.5%
0.00%
-94.7%
Q3 2017$226,000
+1783.3%
4,651
+1862.4%
0.02%
+1800.0%
Q2 2017$12,0000.0%237
-75.1%
0.00%
-50.0%
Q1 2016$12,000
-80.3%
951
-72.5%
0.00%
-66.7%
Q3 2015$61,000
+258.8%
3,461
+249.6%
0.01%
+200.0%
Q2 2015$17,000
+466.7%
990
+953.2%
0.00%
Q1 2015$3,000
-91.2%
94
-92.0%
0.00%
-100.0%
Q4 2014$34,000
-34.6%
1,173
-43.6%
0.00%
-57.1%
Q2 2014$52,000
+108.0%
2,080
+47.6%
0.01%
+75.0%
Q4 2013$25,0001,4090.00%
Other shareholders

There were no reported owners of AERIE PHARMACEUTICALS INC in Q2 2022.

NameSharesValueWeighting ↓
View complete list of AERIE PHARMACEUTICALS INC shareholders